Vertex Pharmaceuticals / CRISPR Therapeutics

    Approach: Gene Editing

    Status: Preclinical

    Press Release announcing Vertex / CRISPR Therapeutics collaboration

    Patent Application

    4.27.20 Press Release announcing Vertex / Affinia deal for AAV delivery technology